Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial

AIMS: Patients with diabetes mellitus (DM) have high platelet reactivity and are at increased risk of ischaemic events and bleeding post-acute coronary syndromes (ACS). In the PLATelet inhibition and patient Outcomes (PLATO) trial, ticagrelor reduced the primary composite endpoint of cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales: James, Stefan, Angiolillo, Dominick J., Cornel, Jan H., Erlinge, David, Husted, Steen, Kontny, Frederic, Maya, Juan, Nicolau, Josë C., Spinar, Jindrich, Storey, Robert F., Stevens, Susanna R., Wallentin, Lars
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2010
Materias:
Esc Fasttrack
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001588/
https://www.ncbi.nlm.nih.gov/pubmed/20802246
http://dx.doi.org/10.1093/eurheartj/ehq325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001588/
https://www.ncbi.nlm.nih.gov/pubmed/20802246
http://dx.doi.org/10.1093/eurheartj/ehq325

Ejemplares similares